Loading...
Summary of the 2019 BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Myeloma Intergroup has organized an annual workshop focused on minimal residual disease (MRD) testing and immune profiling (IP) in multiple myeloma since 2016. In 2019, the workshop took place as an American Society of Hematology (ASH...
Na minha lista:
| Udgivet i: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7529908/ https://ncbi.nlm.nih.gov/pubmed/32589921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.06.011 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|